CTRI/2020/04/024639尚未招募1 期
A Clinical Comparative Study on Virechana Karma and Basti Karma followed by Vidangadi Churna in the Management of Medoroga w.s.r. to Dyslipidaemia.
ational Institute of Ayurveda Jaipur0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •corticosteroids,antidepressants,anticholinergics, immunosuppressant, oestrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study.
- •c)Symptomatic patient with clinical evidence of Heart failure.
- •d)Patients with poorly controlled hypertension (systolic >180 and diastolic >100 mm ofHg)
- •e)Patients with evidence of malignancy.
- •f)Patients on oral contraceptives.
- •g)Alchohol and /or drug abusers.
排除标准
- •a)Unstable angina: Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or severe Arrhythmia in the last six months.
- •b)Patients on prolonged ( >6weeks) medication with corticosteroids,antidepressants,anticholinergics, immunosuppressant, oestrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study.
- •c)Symptomatic patient with clinical evidence of Heart failure.
- •d)Patients with poorly controlled hypertension (systolic >180 and diastolic >100 mm ofHg)
- •e)Patients with evidence of malignancy.
- •f)Patients on oral contraceptives.
- •g)Alchohol and /or drug abusers.
- •h)Hypersensitivity to any of the trial drugs or their ingredients.
- •i)Patients who have completed participation in any other clinical trial drugs or theiringredients in one month period.
- •j)Patients who have received any cholesterol lowering medication (Modern Drug) within last two weeks.
- •k)Associated with any rectal pathology like haemorrhoids, fissure not fit for Virechanaand Basti Karma etc.
- •l)Pregnancy, Lactation and patients having Dyslipidaemia due to drugs e.g.Glucocorticoids, Diuretics etc.
- •m)Patients having Lipid Profile-Serum Cholesterol >400mg dl, Serum Triglycerides > 400mg/dl, LDL Cholesterol > 250 mg/dl,HDL Cholesterol < 20 mg/dl.
研究者
相似试验
尚未招募
2 期
To compare the efficacy of Purgation therapy and Nasal drop therapy, both followed by Oil drip therapy in the management of headache.CTRI/2023/07/054939ational institute of ayurveda
尚未招募
3 期
Comparision of Virechana Karma and Erandadi Vati in Amavata(Rhematoid arthritis)CTRI/2019/02/017572IPGT and RA30
尚未招募
1 期
Effect of Virechana Karma and Durvadi lepa in Ring wormCTRI/2020/05/025477Department of Samhita and Sanskrit
已完成
不适用
Effect of Virechana Karma and Nishadi Vati in the management of Eczema.CTRI/2016/05/006901Govt Akandanand Ayurved College30
尚未招募
2 期
Treatment of Pakshaghata(Hemiplegia) through Virechana Karma And Matra Basti KarmaCTRI/2024/05/067821Government Akhandanand Ayurved College And Hospital